Pentobarbital-D5 (also known as pentobarbitone) is a short acting barbiturate typically used as a sedative, a preanesthetic, and to control convulsions in emergencies. It can also be used for short-term treatment of insomnia but has been largely replaced by the benzodiazepine family of drugs. It is prescribed more frequently for sleep induction than for Sedation but, like similar agents, may lose its effectiveness by the second week of continued administration.
Pentobarbital-D5 – Nembutal Sodium – CAS 52944-66-8
$85.00
Description
Pentobarbital-D5
| Product reference number | PTB-905-FA |
| Full chemical name | 5-Pentadeuteroethyl-5-pentyl-1,3-diazinane-2,4,6-trione[1] |
| Formula | C11H13D5N2O3 |
| Molecular weight | 231.30 |
| CAS Number | 52944-66-8 |
| DEA No. | 2270 CII |
| Appearance | white to off-white crystalline powder |
| IR | corresponds |
| UV max [nm] (mol, solvent) | 242.0 ± 1.0 (7500 ± 500, 0.1N NaOH) |
| Melting point [Celsius] | > 280 |
| HPLC purity [%] | > 98.5 |
| Water content [%] | < 2 |
Pentobarbital-D5 is a member of the class of barbiturates, the structure of which is that of barbituric acid substituted at C-5 by ethyl and sec-pentyl groups. It has a role as a GABAA receptor agonist.
CAS 52944-66-8, Pentobarbitone, Nembutal, Nembutal Sodium, Mebubarbital, Mebumal, Ethaminal, Pentobarbituric acid, Neodorm, Dorsital, Nebralin, Rivadorm, Pentobarbiturate, Pentabarbitone, Sodium pentobarbital, CAS 76-74-4, Pentobarbital-D5
